Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|June 16, 2022
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disordersSarah E Conway, Brian C Healy, Jonathan Zurawski, et al.
Journal of Neurology|September 4, 2021
COVID-19 mRNA vaccination leading to CNS inflammation: a case seriesMahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 24, 2021
Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International RegistryKerstin Hellwig, David Rog, Christopher McGuigan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2021
Risk factors for peripartum depression in women with multiple sclerosisKristen M Krysko, Annika Anderson, Jessica Singh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 3, 2024
Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registryKerstin Hellwig, David Rog, Christopher McGuigan, et al.
Neurology. Clinical Practice|April 8, 2024
Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the MythsEdith L Graham, Riley Bove, Kathleen Costello, et al.
Neurology|September 19, 2007
Thalamic atrophy and cognition in multiple sclerosisM K Houtchens, R H B Benedict, R Killiany, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 19, 2025
Cladribine Is Associated With Stable Cortical Gray Matter Lesion Burden in Multiple Sclerosis: A 7T MRI StudyJonathan Zurawski, Shahamat Tauhid, Brian C Healy, et al.
Annals of Neurology|April 2, 2014
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosisSpyridon Chalkias, Xin Dang, Evelyn Bord, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosisB I Glanz, C M Holland, S A Gauthier, et al.
Pageof 5